Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.1B | 9.9B | 16.0B | 7.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.2B | 3.5B | 3.2B | 2.9B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 218M | 181M | 202M | 202M |
Other income expense | 222M | 189M | 200M | 200M |
Pretax income | 1.3B | 1.6B | 892M | 1.5B |
Tax provision | 196M | 197M | 193M | 305M |
Net income | 1.1B | 1.4B | 699M | 1.2B |
Basic EPS | 1.1 | — | 0.6 | 1.1 |
Diluted EPS | 1.1 | — | 0.6 | 1.1 |
Basic average shares | 643M | — | 647.1M | 649.4M |
Diluted average shares | 648.1M | — | 650.8M | 652.5M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.3B | 1.6B | 892M | 1.5B |
Minority interests | -420M | -484M | -315M | -486M |
Preferred stock dividends | — | — | — | — |